New hope for Tough-to-Treat lung tumors
NCT ID NCT05888402
Summary
This study is testing whether adding an immunotherapy drug called toripalimab to standard chemotherapy and radiation works better for people with large, advanced non-small cell lung cancer that cannot be removed by surgery. The goal is to see if this combination can better control the cancer and help patients live longer without their disease getting worse. About 50 patients will receive the drug before, during, and after their standard chemoradiation treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCAL ADVANCED NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese Academy of Medical Science and Peking Union Medical College
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.